Variant report
Variant | nsv594908 |
---|---|
Chromosome Location | chr4:96246461-96247297 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10002089 | chr4:96246461-96246462 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs17023534 | chr4:96246506-96246507 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs560615886 | chr4:96246612-96246613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs573906803 | chr4:96246661-96246662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs200607543 | chr4:96246666-96246667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs145939615 | chr4:96246674-96246675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562939961 | chr4:96246697-96246698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs72891963 | chr4:96246727-96246728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs148623163 | chr4:96246805-96246806 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs117668626 | chr4:96246876-96246877 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs2626034 | chr4:96246887-96246888 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs35733261 | chr4:96246965-96246966 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs192751874 | chr4:96246970-96246971 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs536738960 | chr4:96247007-96247008 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs28526447 | chr4:96247011-96247012 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs539629738 | chr4:96247020-96247021 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs142061197 | chr4:96247040-96247041 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547316046 | chr4:96247069-96247070 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538952446 | chr4:96247119-96247120 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs151161527 | chr4:96247145-96247146 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571724987 | chr4:96247152-96247153 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534280237 | chr4:96247184-96247185 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554247597 | chr4:96247191-96247192 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs182467483 | chr4:96247226-96247227 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149999978 | chr4:96247231-96247232 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565657575 | chr4:96247237-96247238 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs552837789 | chr4:96247241-96247242 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs66536449 | chr4:96247258-96247259 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs547883887 | chr4:96247268-96247269 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs569688463 | chr4:96247270-96247271 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs563134794 | chr4:96247280-96247281 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 19907438 | CNVD |
Prostate cancer | 16573809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:96223000-96252400 | Weak transcription | Fetal Lung | lung |
2 | chr4:96239600-96250000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr4:96239600-96284400 | Weak transcription | Aorta | Aorta |
4 | chr4:96240600-96248200 | Weak transcription | Brain Anterior Caudate | brain |
5 | chr4:96240800-96246800 | Weak transcription | Brain Cingulate Gyrus | brain |
6 | chr4:96241000-96260800 | Weak transcription | Brain Substantia Nigra | brain |
7 | chr4:96241000-96267600 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
8 | chr4:96242000-96260200 | Weak transcription | Brain Inferior Temporal Lobe | brain |
9 | chr4:96242800-96246800 | Weak transcription | Brain Angular Gyrus | brain |
10 | chr4:96243000-96259600 | Weak transcription | Brain Hippocampus Middle | brain |
11 | chr4:96243400-96263200 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
12 | chr4:96246200-96255000 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
13 | chr4:96246800-96247200 | Enhancers | Brain Cingulate Gyrus | brain |
14 | chr4:96246800-96247600 | Enhancers | Brain Angular Gyrus | brain |
15 | chr4:96247200-96247600 | Enhancers | HUVEC | blood vessel |
16 | chr4:96247200-96265000 | Weak transcription | Brain Cingulate Gyrus | brain |